Therapeutic use of growth factors in the musculoskeletal system in sports-related injuries

Journal of Sports Medicine and Physical Fitness

Volumn 49, Issue 4, 2009, Pages 346-357

  Bachl, N ^a   Derman, W ^b   Engebretsen, L ^c   Goldspink, G ^d   Kinzlbauer, M ^a   Tschan, H ^a   Volpi, P ^e   Venter, D ^f   Wessner, B ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^e IRCCS   (Italy)

^f UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Doping; Growth factors; Musculoskeletal injuries

Indexed keywords

SIGNAL PEPTIDE;

ADAPTATION; ARTICLE; DOPING; HUMAN; INJURY; LIGAMENT; MUSCLE DISEASE; MUSCLE STRENGTH; MUSCULOSKELETAL SYSTEM; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; SPORT INJURY; SPORTS MEDICINE; TENDON INJURY;

ADAPTATION, PHYSIOLOGICAL; ATHLETIC INJURIES; DOPING IN SPORTS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIGAMENTS; MUSCLE STRENGTH; MUSCLE, SKELETAL; MUSCULAR DISEASES; MUSCULOSKELETAL SYSTEM; SIGNAL TRANSDUCTION; SPORTS MEDICINE; TENDON INJURIES;

EID: 77949788648     PISSN: 00224707     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (95)

1. Ljungqvist A, Schwellnus M, Bachl N, Collins M, Cook J, Khan K et al. Consensus Statement. Molecular Basis of Connective Tissue and Muscle Injuries in Sport. Clin Sports Med 2008;27: 231-239
2. Meinel L, Zoidis E, Zapf J, Hassa P, Hottiger MO, Auer JA et al. Localized insulin-like growth factor I delivery to enhance new bone formation. Bone 2003;33: 660-672
3. Nakamura K, Kurokawa T, Kawaguchi H, Kato T, Hanada K, Hiyama Y et al. Stimulation of endosteal bone formation by local intraosseous application of basic fibroblast growth factor in rats. Rev Rhum Engl Ed 1997;64: 101-5.
4. Chuma H, Mizuta H, Kudo S, Takagi K, Hiraki Y. One day exposure to FGF-2 was sufficient for the regenerative repair of full-thickness defects of articular cartilage in rabbits. Osteoarthritis Cartilage 2004;12: 834-842
5. Takafuji H, Suzuki T, OkuboY, Fujimura K, Bessho K. Regeneration of articular cartilage defects in the temporomandibular joint of rabbits by fibroblast growth factor-2: a pilot study. Int J Oral Maxillofac Surg 2007;36: 934-937
6. Bland YS, Critchlow MA, Ashhurst DE. Exogenous fibroblast growth factors-1 and -2 do not accelerate fracture healing in the rabbit. Acta Orthop Scand 1995;66: 543-548
7. Anaguchi Y, Yasuda K, Majima T, Tohyama H, Minami A, Hayashi K. The effect of transforming growth factor-beta on mechanical properties of the fibrous tissue regenerated in the patellar tendon after resecting me central portion. Clin Biomech (Bristol, Avon) 2005;20: 959-965
8. Chan BP, Fu S, Qin L, Lee K, Rolf CG, Chan K. Effects of basic fibroblast growth factor (bFGF) on early stages of tendon healing: a rat patellar tendon model. Acta Orthop Scand 2000;71: 513-518
9. Fukui N, Katsuragawa Y, Sakai H, Oda H, Nakamura K. Effect of local application of basic fibroblast growth factor on ligament healing in rabbits. Rev Rhum Engl Ed 1998;65: 406-414
10. Zhang F, Liu H, Stile F, Lei MP, Pang Y, Oswald TM, et al. Effect of vascular endothelial growth factor on rat Achilles tendon healing. Plast Reconstr Surg 2003;112: 1613-1619
11. Hill M, Wernig A, Goldspink G. Muscle satellite (stem) cell activation during local tissue injury and repair. J Anat 2003;203: 89-99.
12. Witzenbichler B, Mahfoudi A, Soubrier F, Le Roux A, Branellec D, Schultheis HP, et al. Intramuscular gene transfer of fibroblast growth factor-1 using improved pCOR plasmid design stimulates collateral formation in a rabbit ischemic hindlimb model. J Mol Med 2006;84: 491-502.
13. Gustafsson T, Kraus WE. Exercise-induced angiogenesis-related growth and transcription factors in skeletal muscle, and their modification in muscle pathology. Front Biosci 2001;6: 75-89.
14. Nakamura S, Nambu M, Ishizuka T, Hattori H, KanataniY, Takase B, et al. Effect of controlled release of fibroblast growth factor-2 from chitosan/fucoidan micro complex-hydrogel on in vitro and in vivo vascularization. J Biomed Mater Res A 2008;85: 619-627
15. Lee JS, Kim JM, Kim KL, Jang HS, Shin IS, Jeon ES et al. Combined administration of naked DNA vectors encoding VEGF and bFGF enhances tissue perfusion and arteriogenesis in ischemic hindlimb. Biochem Biophys Res Commun 2007;360: 752-758
16. Rosengart TK, Budenbender KT, Duenas M, Mack CA, Zhang QX, Isom OW. Therapeutic angiogenesis: a comparative study of the angiogenic potential of acidic fibroblast growth factor and heparin. J Vase Surg 1997;26: 302-312
17. Eftiumiadou A, Asimakopoulos B, Nikolettos N, Giatromanolaki A, Sivridis E, Papachristou DN et al. Angiogenic effect of intramuscular administration of basic and acidic fibroblast growth factor on skeletal muscles and influence of exercise on muscle angiogenesis. Br J Sports Med 2006;40: 35-39
18. Efthimiadou A, Nikolettos NK, Lambropoulou M, Papadopoulos N, Kontoleon E. Angiogenic effect of intramuscular administration of basic fibroblast growth factor in atrophied muscles: an experimental study in the rat. Br J Sports Med 2006;40: 355-358
19. Husmann I, Soulet L, Gautron J, Martelly I, Barritault D. Growth factors in skeletal muscle regeneration. Cytokine Growth Factor Rev 1996;7: 249-258
20. Lefaucheur JP, Sebille A. Basic fibroblast growth factor promotes in vivo muscle regeneration in murine muscular dystrophy. Neurosci Lett 1995;202: 121-124
21. Lefaucheur JP, Sebille A. Muscle regeneration following injury can be modified in vivo by immune neutralization of basic fibroblast growth factor, transforming growth factor beta 1 or insulin-like growth factor I. J Neuroimmunol 1995;57: 85-91.
22. Mitchell CA, McGeachie JK, Grounds MD. The exogenous administration of basic fibroblast growth factor to regenerating skeletal muscle in mice does not enhance the process of regeneration. Growth Factors 1996;13: 37-55.
23. Kasemkijwattana C, Menetrey J, Bosch P, Somogyi G, Moreland MS, Fu FH et al. Use of growth factors to improve muscle healing after strain injury. Clin Orthop Relat Res 2000;(370): 272-285
24. Iwata Y, Ozaki N, Hirata H, Sugiura Y, Horii E, Nakao E et al. Fibroblast growth factor-2 enhances functional recovery of reinnervated muscle. Muscle Nerve 2006;34: 623-630
25. Wright-Carpenter T, Opolon P, Appell HJ, Meijer H, Wehling P, Mir LM. Treatment of muscle injuries by local administration of autologous conditioned serum: animal experiments using a muscle contusion model. Int J Sports Med 2004;25: 582-587
26. Wright-Carpenter T, Klein P, Schaferhoff P, Appell HJ, Mir LM, Wehling P. Treatment of muscle injuries by local administration of autologous conditioned serum: a pilot study on sportsmen with muscle strains. Int J Sports Med 2004;25: 588-593
27. Gerber HP, Vu TH, Ryan AM, Kowalski J, Werb Z, Ferrara N. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 1999;5: 623-628
28. Takeshita S, Zheng LP, Brogi E, Kearney M, Pu LQ, Bunting S et al. Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest 1994;93: 662-670
29. Li Y, Hazarika S, Xie D, Pippen AM, Kontos CD, Annex BH. In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia. Diabetes 2007;56: 656-665
30. Baumgartner I, Pieczek A, Manor O, Blair R, Kearney M, Walsh K et al. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 1998;97: 1114-1123
31. Kim HJ, Jang SY, Park JI, Byun J, Kim DI, Do YS, Kim et al. Vascular endothelial growth factor-induced angiogenic gene therapy in patients with peripheral artery disease.Exp Mol Med 2004;36: 336-344
32. Rajagopalan S, Mohler ER 3rd, Lederman RJ, Mendelsohn FO, Saucedo JF, Goldman CK, et al. Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication. Circulation 2003;108: 1933-1938
33. Gavin TP, Drew JL, Kubik CJ, Pofahl WE, Hickner RC. Acute resistance exercise increases skeletal muscle angiogenic growth factor expression. Acta Physiol (Oxf) 2007;191: 139-146
34. Arsic N, Zacchigna S, Zentilin L, Ramirez-Correa G, Pattarini L, Salvi A et al. Vascular endothelial growth factor stimulates skeletal muscle regeneration in vivo. Mol Ther 2004;10: 844-854
35. Foster W, Li Y, Usas A, Somogyi G, Huard J. Gamma interferon as an antifibrosis agent in skeletal muscle. J Orthop Res 2003;21: 798-804.
36. McPherron AC, Lee SJ. Double muscling in cattle due to mutations in the myostatin gene. Proc Natl Acad Sci USA 1997;94: 12457-12461
37. Stewart CE, Rittweger J. Adaptive processes in skeletal muscle: molecular regulators and genetic influences. J Musculoskelet Neuronal Interact 2006;6: 73-86.
38. Amthor H, Macharia R, Navarrete R, Schuelke M, Brown SC, Otto A etal. Lack of myostatin results in excessive muscle growth but impaired force generation. Proc Natl Acad Sci USA 2007;104: 1835-1840
39. Rodino-Klapac LR, Haidet AM, Kota J, Handy C, Kaspar BK, Mendell JR. Inhibition of myostatin with emphasis on follistatin as a therapy for muscle disease. Muscle Nerve. 2009;39: 283-296
40. Fedoruk MN, Rupert JL. Myostatin inhibition: a potential performance enhancement strategy? Scand J Med Sci Sports 2008; 18: 123-131
41. Zhu J, Li Y, Shen W, Qiao C, Ambrosio F, Lavasani M, et al. Relationships between transforming growth factor-beta 1, myostatin, and decorin: implications for skeletal muscle fibrosis. J Biol Chem 2007;31;282: 25852-25863
42. Shishkin SS, Krokhina TB, Akhunov VS, Makarov AA, Popov VO. Effects of myostatin and other growth factors on cultured human cells. Prikl Biokhim Mikrobiol 2004;40: 630-633
43. Huygens W, Thomis MA, Peeters MW, Aerssens J, Vlietinck R, Beunen GP. Quantitative trait loci for human muscle strength: linkage analysis of myostatin pathway genes. Physiol Genomics 2005;22: 390-397
44. Steelman CA, Recknor JC, Nettleton D, Reecy JM. Transcriptional profiling of myostatin-knockout mice implicates Wnt signaling in postnatal skeletal muscle growth and hypertrophy. FASEB J 2006;20: 580-582
45. Kami K, Morikawa Y, Sekimoto M, Senba E. Gene expression of receptors for IL-6, LIF, and CNTF in regenerating skeletal muscles. J Histochem Cytochem 2000;48: 1203-1213
46. Spangenburg EE, Booth FW. Leukemia inhibitory factor restores the hypertrophic response to increased loading in the LIF(-/-) mouse. Cytokine 2006;34: 125-130
47. Barnard W, Bower J, Brown MA, Murphy M, Austin L. Leukemia inhibitory factor (LIF) infusion stimulates skeletal muscle regeneration after injury: injured muscle expresses lif mRNA. J Neurol Sci 1994;123: 108-113
48. Gregorevic P, Williams DA, Lynch GS. Effects of leukemia inhibitory factor on rat skeletal muscles are modulated by clenbuterol. Muscle Nerve 2002;25: 194-201.
49. Kurek JB, Bower JJ, Romanella M, Roentgen F, Murphy M, Austin L. The role of leukemia inhibitory factor in skeletal muscle regeneration. Muscle Nerve 1997;20: 815-822
50. Austin L, Bower JJ, Kurek JB, Muldoon CM. Controlled release of leukaemia inhibitory factor (LIF) to tissues. Growth Factors 1997;15: 61-68
51. Hill M, Goldspink G. Expression and splicing of the insulin-like growth factor gene in rodent muscle is associated with muscle satellite (stem) cell activation following local tissue damage. J Physiol 2003;549: 409-418.
52. Haddad F, Adams GR. Selected contribution: acute cellular and molecular responses to resistance exercise. J Appl Physiol 2002;93: 394-403.
53. Goldspink G and Harridge S. Mechanism for Adaption in Skeletal Muscle. In: Komi PV, editor. Strength and Power in Sport: Olympic Encyclopedia of Sports Medicine. Oxford: Blackwell; 2002. p. 231-251
54. Musaro A, McCullagh K, Paul A, Houghton I, Dobrowolny G, Molinaro M, et al. Localized IGF-I transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nature Genetics 2001;27: 195-200.
55. Heinemeier KM, Olesen JL, Schjerling P, Haddad F, Langberg H, Baldwin KM, et al. Short-term strength training and the expression of myostatin and IGF-I isoforms in rat muscle and tendon: differential effects of specific contraction types. J Appl Physiol 2007;102: 573-581
56. Dluzniewska J, Sarnowska A, Beresewicz M, Johnson I, Srai SK, Ramesh B et al. A strong neuroprotective effect of the autonomous Cterminal peptide of IGF-I Ec (MGF) in brain ischemia. FASEB J 2005;19: 1896-1898.
57. CarpenterV, Matthews K, Devlin G, Stuart S, Jensen J, Conaglen J et al. Mechano-growth factor reduces loss of cardiac function in acute myocardial infarction. Heart Lung Circ 2008;17: 33-39
58. Hameed M, Lange KH, Andersen JL, Schjerling P, Kjaer M, Harridge SD, et al. The effect of recombinant human growth hormone and resistance training on IGF-I mRNA expression in the muscles of elderly men. J Physiol 2004;555: 231-240
59. Goldspink G. Gene expression in muscle in response to exercise. J Muscle Res Cell Motil 2003;24: 121-126
60. Lieberman JR, Daluiski A, Einhorn TA. The role of growth factors in the repair of bone. Biology and clinical applications. J Bone Joint Surg Am 2002;84-A: 1032-1044
61. Kato T, Kawaguchi H, Hanada K, Aoyama I, Hiyama Y, Nakamura T, et al. Single local injection of recombinant fibroblast growth factor2 stimulates healing of segmental bone defects in rabbits. J Orthop Res 1998;16: 654-659
62. Zellin G, Linde A. Effects of recombinant human fibroblast growth factor-2 on osteogenic cell populations during orthopic osteogenesis in vivo. Bone 2000;26(2): 161-168
63. Mabilleau G, Aguado E, Stancu IC, Cincu C, Basle MF, Chappard D. Effects of FGF-2 release from a hydrogel polymer on bone mass and microarchitecture. Biomaterials 2008;29: 1593-1600
64. Radomsky ML, Aufdemorte TB, Swain LD, Fox WC, Spiro RC, Poser JW. Novel formulation of fibroblast growth factor-2 in a hyaluronan gel accelerates fracture healing in nonhuman primates. J Orthop Res 1999;17: 607-614
65. Kawaguchi H, Jingushi S, Izumi T, Fukunaga M, Matsushita T, Nakamura T et al Local application of recombinant human fibroblast growth factor-2 on bone repair: A dose-escalation prospective trial on patients with osteotomy. J Orthop Res 2007;25: 480-487
66. Ma T, Gutnick J, Salazar B, Larsen MD, Suenaga E, Zilber S, et al. Modulation of allograft incorporation by continuous infusion of growth factors over a prolonged duration in vivo. Bone 2007;41: 386-392
67. Minamide A,Yoshida M, Kawakami M,Okada M, EnyoY,Hashizume H et al. The effects of bone morphogenetic protein and basic fibroblast growth factor on cultured mesenchymal stem cells for spine fusion. Spine 2007;32: 1067-1071
68. Joyce ME, Jingushi S, Bolander ME. Transforming growth factorbeta in the regulation of fracture repair. Orthop Clin North Am 1990;21: 199-209.
69. Sumner DR, Turner TM, Urban RM, Leven RM, Hawkins M, Nichols EH, et al. Locally delivered rhTGF-beta2 enhances bone ingrowth and bone regeneration at local and remote sites of skeletal injury. J Orthop Res 2001;19: 85-94.
70. Schmidmaier G, Wildemann B, Gabelein T, Heeger J, Kandziora F, Haas NP et al. Synergistic effect of IGF-I and TGF-betal on fracture healing in rats: single versus combined application of IGF-I and TGF-betal. Acta Orthop Scand 2003;74: 604-610
71. Geesink RG, Hoefnagels NH, Bulstra SK. Osteogenic activity of OP1 bone morphogenetic protein (BMP-7) in a human fibular defect. J Bone Joint Surg Br 1999;81: 710-718
72. Friedlaender GE, Perry CR, Cole JD, Cook SD, Cierny G, Muschler GF et al. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am 2001;83(A Suppl1): 151-158
73. Jung RE, Thoma, DS, Hammerle CHF. Assessment of the potential of growth factors for localized alveolar ridge augmentation: A systematic review. J Clin Periodontol 2008;35(8 Suppl): 255-281
74. Avila G, Misch K, Galindo-Moreno P, Wang HL. Implant surface treatment using biomimetic agents. Implant Dent 2009;18: 17-26.
75. Maniscalco P, Gambera D, Bertone C, Rivera F, Crainz E, Urgelli S. Healing of fresh tibial fractures with OP-1. A preliminary report. Acta Biomed 2002;73: 27-33.
76. McKee MD. Recombinant human bone morphogenic protein-7: applications for clinical trauma. J Orthop Trauma 2005;19(10 Suppl): 26-28
77. Delloye C, Suratwala SJ, Cornu O, Lee FY. Treatment of allograft nonunions with recombinant human bone morphogenetic proteins (rhBMP). Acta Orthop Belg 2004;70: 591-597
78. Govender S, Csimma C, Genant HK, Valentin-OpranA, Amit Y, Arbel R et al. BMP-2 Evaluation in Surgery for Tibial Trauma (BESTT) Study Group. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 2002;84-A: 2123-2134
79. Nash TJ, Howlett CR, Martin C, Steele J, Johnson KA, Hicklin DJ. Effect of platelet-derived growth factor on tibial osteotomies in rabbits. Bone 1994;15: 203-208
80. Rozman P, Boita Z. Use of platelet growth factors in treating wounds and soft-tissue injuries. Acta Dermatovenerol Alp Panonica Adriat 2007;16: 156-165
81. Zhang CQ, Yuan T, Zeng BF. Experimental study of the effect of platelet-rich plasma on osteogenesis in rabbit. Chin Med J 2004;117: 1853-1855
82. Menta S, Watson JT. Platelet rich concentrate: basic science and current chnical applications. J Orthop Trauma 2008;22: 432-438
83. Creaney L, Hamilton B. Growth Factor Delivery Methods in the Management of Sports Injuries:The State of Play. Br J Sports Med 2008;42: 314-320
84. Yang SY, Sales KM, Fuller BJ, Seifalian AM, Winslet MC. Inducing apoptosis of human colon cancer cells by an IGF-ID domain analogue peptide. Mol Cancer 2008;8: 7-17.
85. Hsu C, Chang J. Clinical implications of growth factors in flexor tendon wound healing. J Hand Surg [Am] 2004;29: 551-563
86. Kobayashi D, Kurosaka M, Yoshiya S, Mizuno K. Effect of basic fibroblast growth factor on the healing of defects in the canine anterior cruciate ligament. Knee Surg Sports Traumatol Arthrosc 1997;5: 189-194
87. HamadaY, Katoh S, Hibino N, Kosaka H, Hamada D, Yasui N. Effects of monofilament nylon coated with basic fibroblast growth factor on endogenous intrasynovial flexor tendon healing. J Hand Surg 2006;31: 530-540
88. Kohno T, Ishibashi Y, Tsuda E, Kusumi T, Tanaka M, Toh S. Immunohistochemical demonstration of growth factors at the tendon-bone interface in anterior cruciate ligament reconstruction using a rabbit model. J Orthop Sci 2007;12: 67-73.
89. Petersen W, Varoga D, Zantop T, Hassenpflug J, Mentlein R, Pufe T. Cyclic strain influences the expression of the vascular endothelial growth factor (VEGF) and the hypoxia inducible factor 1 alpha (HIF-lalpha) in tendon fibroblasts. J Orthop Res 2004;22: 847-853
90. Molloy T, Wang Y, Murrell G. The roles of growth factors in tendon and ligament healing. Sports Med 2003;33: 381-394
91. Kondo E, Yasuda K, Yamanaka M, Minami A, Tohyama H. Effects of administration of exogenous growth factors on biomechanical properties of the elongation-type anterior cruciate ligament injury with partial laceration. Am J Sports Med 2005;33: 188-196
92. Okamoto S, Tohyama H, Kondo E, AnaguchiY, Onodera S, Hayashi K et al. Ex vivo supplementation of TGF-betal enhances the fibrous tissue regeneration effect of synovium-derived fibroblast transplantation in a tendon defect: a biomechanical study. Knee Surg Sports Traumatol Arthrose 2008;16: 333-339
93. Chan BP, Fu SC, Qin L, Rolf C, Chan KM. Supplementation-time dependence of growth factors in promoting tendon healing. Clin Orthop Relat Res 2006;448: 240-247
94. Letson AK, Dahners LE. The effect of combinations of growth factors on ligament healing. Clin Orthop Relat Res 1994;308: 207-212
95. Anitua E, Sanchez M, Nurden AT, Nurden P, Orive G, Andia I. New insights into and novel applications for platelet-rich fibrin therapies. Trends Biotechnol 2006;24: 227-234